US 11492368
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted A61KA61K2039/55511A61K2039/55561
Quick answer
US patent 11492368 (Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway) held by The Board of Regents of the University of Texas System expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/55511, A61K2039/55561, A61K31/7084, A61K39/39